The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Atara Biotherapeutics, Inc. Common Stock 046513107 29,182 1,876,650 SH   SOLE   1,876,650 0 0
Rapt Therapeutics, Inc. Common Stock 75382E109 41,234 1,297,063 SH   SOLE   1,297,063 0 0
Twilio Inc. Class A Common Stock 90138F102 74,165 188,160 SH   SOLE   188,160 0 0
Upstart Holdings, Inc. Common Stock 91680M107 79,417 635,841 SH   SOLE   635,841 0 0